View in EDS HTML Full Text PDF Full Text

Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.

Saved in:
Bibliographic Details
Title: Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.
Authors: Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., Lang P; Critical Path Institute, Tucson, Arizona, USA., O'Doherty IM; Critical Path Institute, Tucson, Arizona, USA., David SE; Critical Path Institute, Tucson, Arizona, USA., Muse RN; Critical Path Institute, Tucson, Arizona, USA., Karpen SR; Critical Path Institute, Tucson, Arizona, USA., Song LS; Critical Path Institute, Tucson, Arizona, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA., Burton JK; Critical Path Institute, Tucson, Arizona, USA.
Corporate Authors: Type-1 Diabetes Consortium (T1DC)
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 May; Vol. 111 (5), pp. 1133-1141. Date of Electronic Publication: 2022 Mar 11.
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35276013
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Podichetty+JT%22">Podichetty JT</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Lang+P%22">Lang P</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22O'Doherty+IM%22">O'Doherty IM</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22David+SE%22">David SE</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Muse+RN%22">Muse RN</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Karpen+SR%22">Karpen SR</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Song+LS%22">Song LS</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Romero+K%22">Romero K</searchLink>; Critical Path Institute, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Burton+JK%22">Burton JK</searchLink>; Critical Path Institute, Tucson, Arizona, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Type-1+Diabetes+Consortium+%28T1DC%29%22">Type-1 Diabetes Consortium (T1DC)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2022 May; Vol. 111 (5), pp. 1133-1141. <i>Date of Electronic Publication: </i>2022 Mar 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35276013
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.2559
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1133
    Titles:
      – TitleFull: Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Podichetty JT
      – PersonEntity:
          Name:
            NameFull: Lang P
      – PersonEntity:
          Name:
            NameFull: O'Doherty IM
      – PersonEntity:
          Name:
            NameFull: David SE
      – PersonEntity:
          Name:
            NameFull: Muse RN
      – PersonEntity:
          Name:
            NameFull: Karpen SR
      – PersonEntity:
          Name:
            NameFull: Song LS
      – PersonEntity:
          Name:
            NameFull: Romero K
      – PersonEntity:
          Name:
            NameFull: Burton JK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 111
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1